Daeheung-dong Ginseng (Panax ginseng)

Daeheung-dong Ginseng is a cultivar of Panax ginseng grown in the Daeheung-dong region of Korea, containing ginsenosides—particularly Rb1, Rg1, and Re—as its primary bioactive compounds. These saponins modulate the HPA axis and interact with steroid hormone receptors to support adaptogenic, cognitive, and anti-fatigue effects.

Origin & History

Daeheung-dong Ginseng is the DD1 cultivar of Panax ginseng, developed through selective breeding programs in South Korea for superior yield (13.16-19.20% higher than local controls) and adaptability. This Korean-registered variety is cultivated under shade for 4-6 years, selected for its high multi-stem rate (over 50% in four-year-old plants) and elevated ginsenoside content.

Historical & Cultural Context

Daeheung-dong Ginseng is a modern cultivar registered after 2006 trials, building on Korean landraces used in Traditional Korean Medicine for over 2,000 years. Panax ginseng roots have historically been used for vitality, immunity, and longevity, with steaming methods creating red ginseng to enhance efficacy.

Health Benefits

• No clinical trials specific to Daeheung-dong Ginseng were identified in the research
• General Panax ginseng studies suggest cognitive benefits (evidence quality: not specified for this cultivar)
• May support fatigue reduction based on broader ginseng research (evidence quality: not established for DD1)
• Traditional use suggests immune support (evidence quality: traditional use only, no DD1-specific data)
• Potential antioxidant effects via Nrf2 pathway activation (evidence quality: mechanistic speculation only)

How It Works

Ginsenosides in Panax ginseng, including Rb1 and Rg1, interact with glucocorticoid and estrogen receptors and modulate the hypothalamic-pituitary-adrenal (HPA) axis to regulate cortisol secretion under stress. Rg1 activates PI3K/Akt signaling pathways, promoting neuroprotection and synaptic plasticity through increased BDNF expression. Additionally, ginsenosides inhibit acetylcholinesterase activity and stimulate nitric oxide synthase (eNOS), improving cerebral blood flow and cholinergic neurotransmission.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to the Daeheung-dong (DD1) cultivar were identified in the research. While general Panax ginseng studies exist (PMID 32083502 addresses cultivar characteristics), none link directly to DD1 clinical outcomes in humans.

Clinical Summary

No clinical trials specific to the Daeheung-dong cultivar have been published in peer-reviewed literature as of 2024, making cultivar-specific efficacy claims unsupported by direct evidence. Broader Panax ginseng randomized controlled trials, including a 2010 double-blind RCT by Kennedy et al. (n=30), found that 200–400 mg standardized ginseng extract improved working memory and calmness scores significantly versus placebo. A 2013 systematic review of 10 RCTs found moderate evidence for fatigue reduction, though heterogeneity in dosing (100–3000 mg/day) and ginsenoside standardization limits generalizability. Until cultivar-specific studies are conducted, benefits attributed to Daeheung-dong Ginseng are extrapolated from general Panax ginseng data and should be interpreted cautiously.

Nutritional Profile

Panax ginseng root (general cultivar basis, as DD1-specific analytical data is not publicly available): Ginsenosides (triterpenoid saponins) are the primary bioactive compounds, typically 2–3% total ginsenoside content by dry weight in commercial roots, with key fractions including Rb1 (~0.3–0.5% dw), Rg1 (~0.1–0.3% dw), Rc, Rb2, and Rd; protopanaxadiol (PPD) and protopanaxatriol (PPT) ginsenosides are the two major structural groups. Polysaccharides (ginsenans) account for approximately 10–20% dry weight and contribute to immunomodulatory activity. Polyacetylenes (panaxynol, panaxydol) are present at trace levels (~0.01–0.05% dw) with reported cytotoxic and antifungal properties. Protein content is approximately 12–14% dry weight, comprising various amino acids including arginine, which may contribute to nitric oxide pathways. Carbohydrates constitute the bulk at ~60–70% dry weight, predominantly as starch and free sugars (sucrose, glucose, fructose). Fat content is low at ~1–2% dry weight, including linoleic and palmitic acids. Fiber (dietary) is approximately 2–5% dry weight. Minerals present include potassium (~400–600 mg/100g dw), calcium (~60–100 mg/100g dw), phosphorus (~150–200 mg/100g dw), magnesium (~30–50 mg/100g dw), and trace iron (~2–4 mg/100g dw). B-vitamins are present in minor quantities, including niacin (~1–2 mg/100g dw) and thiamine (~0.1 mg/100g dw); Vitamin C is detectable at low levels (~2–5 mg/100g dw) and degrades with processing. Bioavailability note: Ginsenosides have low oral bioavailability (~2–15%) in native form; gut microbiota metabolize compound K and other metabolites that are more bioavailable and pharmacologically active. Steam processing (red ginseng) increases concentrations of Rg3, Rk1, and Rg5 through deglycosylation. No DD1 (Daeheung-dong cultivar)-specific compositional assay data has been identified in peer-reviewed literature; values above reflect Panax ginseng species norms and should be treated as approximations until cultivar-specific analysis is conducted.

Preparation & Dosage

No clinically studied dosage ranges specific to Daeheung-dong Ginseng were found. General Panax ginseng cultivars are often standardized to ginsenoside content, but no extract, powder, or standardized form dosages from DD1 trials are reported. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rhodiola rosea, Ashwagandha, Cordyceps, American ginseng, Eleuthero

Safety & Interactions

Panax ginseng is generally well tolerated at doses of 200–400 mg/day of standardized extract (typically 4–7% ginsenosides), with the most common side effects being insomnia, headache, and gastrointestinal upset, particularly at higher doses. Ginseng has documented interactions with warfarin by potentially inhibiting CYP2C9 and altering platelet aggregation, and it may potentiate or antagonize the effects of antidiabetic medications by lowering blood glucose. It is contraindicated in individuals with hormone-sensitive conditions due to its estrogen-like activity, and its safety during pregnancy and lactation has not been established, warranting avoidance in those populations. Individuals scheduled for surgery should discontinue use at least seven days prior due to anticoagulant and hypoglycemic risks.